Nathaniel S. Gardiner J.D.
Net Worth

Last updated:

What is Nathaniel S. Gardiner J.D. net worth?

The estimated net worth of Mr. Nathaniel S. Gardiner J.D. is at least $7,103,302 as of 26 Feb 2024. He owns shares worth $571,812 as insider, has earned $334,790 from insider trading and has received compensation worth at least $6,196,700 in Enanta Pharmaceuticals, Inc..

What is the salary of Nathaniel S. Gardiner J.D.?

Mr. Nathaniel S. Gardiner J.D. salary is $619,670 per year as Senior Vice President, Gen. Counsel & Sec. in Enanta Pharmaceuticals, Inc..

How old is Nathaniel S. Gardiner J.D.?

Mr. Nathaniel S. Gardiner J.D. is 71 years old, born in 1954.

What stocks does Nathaniel S. Gardiner J.D. currently own?

As insider, Mr. Nathaniel S. Gardiner J.D. owns shares in one company:

Company Title Shares Price per share Total value
Enanta Pharmaceuticals, Inc. (ENTA) Senior Vice President, Gen. Counsel & Sec. 68,154 $8.39 $571,812

What does Enanta Pharmaceuticals, Inc. do?

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

ENTA logo
ENTA
Enanta Pharmaceuticals, Inc.
$8.39

Nathaniel S. Gardiner J.D. insider trading

Enanta Pharmaceuticals, Inc.

Mr. Nathaniel S. Gardiner J.D. has made 2 insider trades between 2015-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 6,667 units of ENTA stock on 18 Apr 2023. As of 26 Feb 2024 he still owns at least 68,154 units of ENTA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 5,187 $8.99 $46,631
Option
Stock Option (Right to Buy) 5,187 $8.99 $46,631
Sale
Common Stock 2,412 $9.63 $23,228
Option
Stock Option (Right to Buy) 6,667 $30 $200,010
Option
Common Stock 6,667 $30 $200,010
Option
Restricted Stock Units 5,250 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Stock Option (right to buy) 1,667 $30 $50,010
Option
Common Stock 1,667 $30 $50,010
Option
Stock Option (right to buy) 1,666 $30 $49,980
Option
Common Stock 1,666 $30 $49,980
Option
Common Stock 3,000 $30 $90,000
Option
Stock Option (right to buy) 3,000 $30 $90,000
Option
Restricted Stock Units 5,250 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Stock Option (right to buy) 1,592 $31.42 $50,021
Option
Common Stock 1,592 $31.42 $50,021
Option
Stock Option (right to buy) 5,000 $30 $150,000
Option
Common Stock 5,000 $30 $150,000
Option
Stock Option (right to buy) 3,295 $31.42 $103,529
Option
Common Stock 6,590 $31.42 $207,058
Option
Common Stock 2,519 $33.06 $83,278
Option
Stock Option (right to buy) 2,519 $33.06 $83,278
Sale
Common Stock 3,270 $95.28 $311,562
Option
Common Stock 2,000 $34.7 $69,400
Option
Stock Option (right to buy) 2,000 $34.7 $69,400
Option
Stock Option (right to buy) 2,000 $34.7 $69,400
Option
Common Stock 2,000 $34.7 $69,400
Option
Stock Option (right to buy) 1,500 $34.7 $52,050
Option
Common Stock 1,500 $34.7 $52,050
Option
Common Stock 4,300 $34.7 $149,210
Option
Stock Option (right to buy) 4,300 $34.7 $149,210
Purchase
Common Stock 500 $24.45 $12,223
Purchase
Common Stock 1,000 $33.29 $33,285
Purchase
Common Stock 400 $33.1 $13,240

Enanta Pharmaceuticals key executives

Enanta Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: